Company Filing History:

9 out of 43

Praecis Pharmaceuticals, Inc.

patents

2 out of 2,076

Janssen Pharmaceutica Nv

patents

1 out of 1

Johnson & Johnson Pharmaceuticals Research & Development, L.l.c.

patent

Years Active: 2003-2013

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8367825 - Substituted pyrimidinyl oxime kinase inhibitors (2013-02-05),

2. 8153791 - Substituted pyrimidinyl oxime kinase inhibitors (2012-04-10),

3. 7550474 - Substituted phenyl acetamides and their use as protease inhibitors (2009-06-23),

4. 7405194 - Therapeutic agents and methods of use thereof for the treatment of melanoma (2008-07-29),

5. 7348307 - Methionine aminopeptidase-2 inhibitors and methods of use thereof (2008-03-25),

6. 7268111 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2007-09-11),

7. 7157420 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2007-01-02),

8. 7105482 - Methionine aminopeptidase-2 inhibitors and methods of use thereof (2006-09-12),

9. 7084108 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2006-08-01),

10. 7037890 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2006-05-02),

11. 6919307 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2005-07-19),

12. 6548477 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2003-04-15),

Title: Innovations by Inventor Lily Lee: A Focus on Kinase Inhibitors

Introduction

Lily Lee is a renowned inventor based in Edison, NJ, who has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 12 patents, she has focused her research on therapeutic solutions for protein kinase mediated diseases.

Latest Patents

Among her latest patents are groundbreaking innovations related to substituted pyrimidinyl oxime kinase inhibitors. These inventions are directed towards substituted pyrimidine compounds of a specific formula, along with their synthesis and applications. The primary goal of her work is to provide treatment, prevention, or amelioration for chronic or acute diseases, disorders, or conditions associated with protein kinases.

Career Highlights

Lily Lee has had a distinguished career, having worked with prominent companies in the pharmaceutical industry, including Praecis Pharmaceuticals, Inc. and Janssen Pharmaceutica. Her work involves pioneering research and a dedication to advancing medical science through innovative therapies.

Collaborations

Throughout her career, Lily has collaborated with esteemed colleagues, including Gary Olson and Christopher Self. These partnerships have allowed her to enhance the scope and impact of her research, driving advancements in the field of kinase inhibitors.

Conclusion

Lily Lee's contributions to scientific research and patent development underscore her role as an influential inventor. Her innovative approaches to kinase inhibitors not only enrich the pharmaceutical landscape but also offer hope for improved treatments for various diseases. As she continues to push the boundaries of science, her work will undoubtedly lead to significant advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.